Jazz Pharmaceuticals plc 4

Rick E. Winningham had a total of 1,706 Jazz Pharmaceuticals plc ordinary shares sold/withheld on August 31, 2026 to satisfy tax obligations from RSU vesting, leaving him with 9,466 directly owned shares.

On August 31, 2026, Rick E. Winningham, a reporting insider of Jazz Pharmaceuticals plc, disposed of small blocks of ordinary shares in two Form 4 reportable transactions classified as code “F,” indicating shares were withheld or sold solely to cover tax obligations associated with the vesting of previously granted restricted stock units. The transactions involved 1,692 shares at approximately $241.39 per share and 14 shares at approximately $244.64 per share, for an aggregate value of roughly $411,000. Following these tax-related dispositions, Winningham reported direct ownership of 9,466 ordinary shares of Jazz Pharmaceuticals plc. These transactions appear to be routine, non-discretionary sales tied to equity compensation rather than open-market trading decisions.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001302443-26-000015

Alert Tier

5